Titlebook: Biomarkers in Kidney Disease; Vinood B. Patel,Victor R. Preedy Living reference work 20200th edition Application to prognosis.Biomarkers

Introduction

Biomarkers in Kidney Transplantation,of biomarkers. This review is focused on recently developed biomarkers in acute rejection and tolerance as the two most important processes in decision-making about immunosuppressive therapy. The clinical utilities and limitations of these markers are discussed in details.

漫不經(jīng)心

BLyS and APRIL Cytokines as Biomarkers of Kidney Diseases,e, bone marrow, synovium, and kidney. Even though both cytokines share a common receptor on the B-cells, however, their roles in B-cell activation are significantly different. When BLyS is activated, this will result in severe B-cell hyperplasia in BLyS-transgenic mice. In contrast, when APRIL is ac

惡心

哄騙

Chemokines as Potential Markers in Pediatric Renal Diseases, diseases were CCL2/MCP-1 and CXCL8/IL-8. In glomerular diseases, high urinary levels of CCL2/MCP-1 have been associated to FSGS, lupus nephritis and IgA nephropathy. On the other hand, urinary levels of CXCL8/IL-8 positively correlated with proteinuria in pediatric patients with primary nephrotic s

宴會(huì)

Chronic Allograft Damage Index (CADI) as a Biomarker in Kidney Transplantation,tocol biopsies taken after transplantation, correlates with graft function and later outcome and can be used as a surrogate marker in clinical trials. CADI has also been extensively studied in experimental models of kidney transplantation. In addition, CADI can be useful in clinical decision-making,